The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches

Cell Reports

Volumn 15, Issue 11, 2016, Pages 2500-2509

  Mineo, Marco ^a   Ricklefs, Franz ^a,b   Rooj, Arun K ^a   Lyons, Shawn M ^a   Ivanov, Pavel ^a   Ansari, Khairul I ^a,d   Nakano, Ichiro ^c   Chiocca, E Antonio ^a   Godlewski, Jakub ^a   Bronisz, Agnieszka ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c University of Alabama at Birmingham   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT RNA HELICASE; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1 ALPHA ANTISENSE RNA 2; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INSULIN LIKE GROWTH FACTOR 2 BINDING PROTEIN 2; LONG UNTRANSLATED RNA; RNA HELICASE; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG; LONG NONCODING RNA HIF1A-AS2, HUMAN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL FATE; CELL GROWTH; CELL HETEROGENEITY; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; STEM CELL NICHE; STEM CELL SELF-RENEWAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; CANCER STEM CELL; CELL LINEAGE; DISEASE COURSE; GENETIC HETEROGENEITY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; CELL LINEAGE; DISEASE PROGRESSION; GENETIC HETEROGENEITY; GLIOBLASTOMA; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASTIC STEM CELLS; RNA, LONG NONCODING; RNA, NEOPLASM; STEM CELL NICHE;

EID: 84974687001     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.018     Document Type: Article

References (62)

1. Bhat K.P., Balasubramaniyan V., Vaillant B., Ezhilarasan R., Hummelink K., Hollingsworth F., Wani K., Heathcock L., James J.D., Goodman L.D., et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 2013, 24:331-346.
2. Bozdag S., Li A., Baysan M., Fine H.A. Master regulators, regulatory networks, and pathways of glioblastoma subtypes. Cancer Inform. 2014, 13(Suppl 3):33-44.
3. Brat D.J., Castellano-Sanchez A.A., Hunter S.B., Pecot M., Cohen C., Hammond E.H., Devi S.N., Kaur B., Van Meir E.G. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004, 64:920-927.
4. Bronisz A., Wang Y., Nowicki M.O., Peruzzi P., Ansari K.I., Ogawa D., Balaj L., De Rienzo G., Mineo M., Nakano I., et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 2014, 74:738-750.
5. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., Sulman E.P., Anne S.L., Doetsch F., Colman H., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
6. Celiku O., Johnson S., Zhao S., Camphausen K., Shankavaram U. Visualizing molecular profiles of glioblastoma with GBM-BioDP. PLoS ONE 2014, 9:e101239.
7. Chang Y.N., Zhang K., Hu Z.M., Qi H.X., Shi Z.M., Han X.H., Han Y.W., Hong W. Hypoxia-regulated lncRNAs in cancer. Gene 2016, 575:1-8.
8. Chatel-Chaix L., Germain M.A., Motorina A., Bonneil É., Thibault P., Baril M., Lamarre D. A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production. J. Virol. 2013, 87:11704-11720.
9. Chiappetta G., Avantaggiato V., Visconti R., Fedele M., Battista S., Trapasso F., Merciai B.M., Fidanza V., Giancotti V., Santoro M., et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996, 13:2439-2446.
10. Cooper L.A., Gutman D.A., Chisolm C., Appin C., Kong J., Rong Y., Kurc T., Van Meir E.G., Saltz J.H., Moreno C.S., Brat D.J. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am. J. Pathol. 2012, 180:2108-2119.
11. Du Z., Fei T., Verhaak R.G., Su Z., Zhang Y., Brown M., Chen Y., Liu X.S. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 2013, 20:908-913.
12. Fatica A., Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 2014, 15:7-21.
13. Flynn R.A., Chang H.Y. Active chromatin and noncoding RNAs: an intimate relationship. Curr. Opin. Genet. Dev. 2012, 22:172-178.
14. Frattini V., Trifonov V., Chan J.M., Castano A., Lia M., Abate F., Keir S.T., Ji A.X., Zoppoli P., Niola F., et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 2013, 45:1141-1149.
15. Fusco A., Fedele M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer 2007, 7:899-910.
16. Godlewski J., Krichevsky A.M., Johnson M.D., Chiocca E.A., Bronisz A. Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment. Neuro-oncol. 2015, 17:652-662.
17. Halliday J., Helmy K., Pattwell S.S., Pitter K.L., LaPlant Q., Ozawa T., Holland E.C. In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift. Proc. Natl. Acad. Sci. USA 2014, 111:5248-5253.
18. Huarte M. The emerging role of lncRNAs in cancer. Nat. Med. 2015, 21:1253-1261.
19. Janiszewska M., Suvà M.L., Riggi N., Houtkooper R.H., Auwerx J., Clément-Schatlo V., Radovanovic I., Rheinbay E., Provero P., Stamenkovic I. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev. 2012, 26:1926-1944.
20. Johnson D.R., O'Neill B.P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 2012, 107:359-364.
21. Jones D.L., Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 2008, 9:11-21.
22. Joseph J.V., Conroy S., Pavlov K., Sontakke P., Tomar T., Eggens-Meijer E., Balasubramaniyan V., Wagemakers M., den Dunnen W.F., Kruyt F.A. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Cancer Lett. 2015, 359:107-116.
23. Kim S.H., Ezhilarasan R., Phillips E., Gallego-Perez D., Sparks A., Taylor D., Ladner K., Furuta T., Sabit H., Chhipa R., et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell 2016, 29:201-213.
24. Kunej T., Obsteter J., Pogacar Z., Horvat S., Calin G.A. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. Crit. Rev. Clin. Lab. Sci. 2014, 51:344-357.
25. Lathia J.D., Mack S.C., Mulkearns-Hubert E.E., Valentim C.L., Rich J.N. Cancer stem cells in glioblastoma. Genes Dev. 2015, 29:1203-1217.
26. Lee T., Di Paola D., Malina A., Mills J.R., Kreps A., Grosse F., Tang H., Zannis-Hadjopoulos M., Larsson O., Pelletier J. Suppression of the DHX9 helicase induces premature senescence in human diploid fibroblasts in a p53-dependent manner. J. Biol. Chem. 2014, 289:22798-22814.
27. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
28. Liu B., Pang B., Liu H., Arakawa Y., Zhang R., Feng B., Zhong P., Murata D., Fan H., Xin T., et al. High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme. Pathol. Res. Pract. 2015, 211:596-600.
29. Mao P., Joshi K., Li J., Kim S.H., Li P., Santana-Santos L., Luthra S., Chandran U.R., Benos P.V., Smith L., et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl. Acad. Sci. USA 2013, 110:8644-8649.
30. Marx V. A blooming genomic desert. Nat. Methods 2014, 11:135-138.
31. Mathew L.K., Skuli N., Mucaj V., Lee S.S., Zinn P.O., Sathyan P., Imtiyaz H.Z., Zhang Z., Davuluri R.V., Rao S., et al. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc. Natl. Acad. Sci. USA 2014, 111:291-296.
32. Meacham C.E., Morrison S.J. Tumour heterogeneity and cancer cell plasticity. Nature 2013, 501:328-337.
33. Minajigi A., Froberg J.E., Wei C., Sunwoo H., Kesner B., Colognori D., Lessing D., Payer B., Boukhali M., Haas W., Lee J.T. Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science 2015, 349:aab2276.
34. Mineo M., Garfield S.H., Taverna S., Flugy A., De Leo G., Alessandro R., Kohn E.C. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis 2012, 15:33-45.
35. Moore M.J., Zhang C., Gantman E.C., Mele A., Darnell J.C., Darnell R.B. Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis. Nat. Protoc. 2014, 9:263-293.
36. Nakano I. Proneural-mesenchymal transformation of glioma stem cells: do therapies cause evolution of target in glioblastoma?. Future Oncol. 2014, 10:1527-1530.
37. Network T.C. Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2013, 494:506.
38. Orr B.A., Eberhart C.G. Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. Am. J. Pathol. 2012, 180:1768-1771.
39. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Siu I.M., Gallia G.L., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
40. Pastori C., Kapranov P., Penas C., Peschansky V., Volmar C.H., Sarkaria J.N., Bregy A., Komotar R., St Laurent G., Ayad N.G., Wahlestedt C. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc. Natl. Acad. Sci. USA 2015, 112:8326-8331.
41. Patel A.P., Tirosh I., Trombetta J.J., Shalek A.K., Gillespie S.M., Wakimoto H., Cahill D.P., Nahed B.V., Curry W.T., Martuza R.L., et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014, 344:1396-1401.
42. Peruzzi P., Bronisz A., Nowicki M.O., Wang Y., Ogawa D., Price R., Nakano I., Kwon C.H., Hayes J., Lawler S.E., et al. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro-oncol. 2013, 15:1212-1224.
43. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9:157-173.
44. Piao Y., Liang J., Holmes L., Henry V., Sulman E., de Groot J.F. Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clin. Cancer Res. 2013, 19:4392-4403.
45. Qureshi I.A., Mehler M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 2012, 13:528-541.
46. Reardon D.A., Ligon K.L., Chiocca E.A., Wen P.Y. One size should not fit all: advancing toward personalized glioblastoma therapy. Discov. Med. 2015, 19:471-477.
47. Ricklefs F., Mineo M., Rooj A.K., Nakano I., Charest A., Weissleder R., Breakefield X.O., Chiocca E.A., Godlewski J., Bronisz A. Extracellular vesicles from high grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity. Cancer Res. 2016, canres.3432.2015.
48. Semenza G.L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Invest. 2013, 123:3664-3671.
49. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 2008, 9:285-296.
50. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
51. Soeda A., Hara A., Kunisada T., Yoshimura S., Iwama T., Park D.M. The evidence of glioblastoma heterogeneity. Sci. Rep. 2015, 5:7979.
52. Sørensen M.D., Fosmark S., Hellwege S., Beier D., Kristensen B.W., Beier C.P. Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma. Adv. Exp. Med. Biol. 2015, 853:111-138.
53. Suvà M.L., Rheinbay E., Gillespie S.M., Patel A.P., Wakimoto H., Rabkin S.D., Riggi N., Chi A.S., Cahill D.P., Nahed B.V., et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 2014, 157:580-594.
54. Szklarczyk D., Franceschini A., Wyder S., Forslund K., Heller D., Huerta-Cepas J., Simonovic M., Roth A., Santos A., Tsafou K.P., et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015, 43:D447-D452.
55. Takahashi K., Yan I.K., Haga H., Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J. Cell Sci. 2014, 127:1585-1594.
56. Thrash-Bingham C.A., Tartof K.D. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl. Cancer Inst. 1999, 91:143-151.
57. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
58. Vassallo I., Zinn P., Lai M., Rajakannu P., Hamou M.F., Hegi M.E. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 2016, 35:12-21.
59. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. Cancer Genome Atlas Research Network.
60. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
61. Zhang J.X., Han L., Bao Z.S., Wang Y.Y., Chen L.Y., Yan W., Yu S.Z., Pu P.Y., Liu N., You Y.P., et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro-oncol. 2013, 15:1595-1603. Chinese Glioma Cooperative Group.
62. Zheng S., Houseman E.A., Morrison Z., Wrensch M.R., Patoka J.S., Ramos C., Haas-Kogan D.A., McBride S., Marsit C.J., Christensen B.C., et al. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro-oncol. 2011, 13:280-289.